Pharma Pathway

DECEMBER 1, 2022

Emcure Pharmaceuticals-Walk-In Interviews for Quality Assurance/ Engineering On 4th Dec’ 2022. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. Date of Interview: 4th Dec’ 2022. Job Description. Mechanical.

Engineering 78

Engineering Pharmaceutical Competition Manufacturing 78

Impetus Digital

AUGUST 2, 2024

In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex. Looking back at 2023 , AI for drug discovery saw both wins and losses.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

Pharma Pathway

SEPTEMBER 23, 2022

Emcure Pharmaceuticals-Walk-In Interviews for Quality Assurance (Injectable) On 25th Sept’ 2022. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. Date of Interview: 25th Sept’ 2022. Job Description.

Pharmaceutical 80

Pharmaceutical Competition Manufacturing Marketing 80

Clarivate

DECEMBER 19, 2022

million lives, per Clarivate TM enrollment data as of January 2022. Under its CenterWell subsidiary Humana planned to operate 240-260 senior-only primary-care clinics by the end of 2022 while entering new markets such as Dallas-Fort Worth, Phoenix, Louisville, Nashville and Charlotte. million covered lives, ahead of No.

Competition 52

Competition Retail Insurance Marketing 52

European Pharmaceutical Review

OCTOBER 5, 2022

The benefits of exposing students to the industry this way enables both parties to share knowledge, experience and provides students networking opportunities that can be difficult to obtain for such a competitive industry, said ABPI. It also found that The University of Bath, UK hosted the most industry placements: 61 in 2019 and 2022.

Pharma 104

Pharma Training Networking Pharmaceutical 104

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. billion in 2022, and there has been speculation that the return rate could rise into the 30%-plus range in future. billion in 2021 to £1.8

Pharma 72

Pharma Government Manufacturing Medicine 72

European Pharmaceutical Review

AUGUST 22, 2022

However, China and India are set to be fierce competition over the next decade, with 30 percent of respondents suggesting they would offshore >50 percent of clinical trials and operations to India, China or other lower-cost countries over the next five years.

Biopharma 98

Biopharma Manufacturing Marketing Competition 98

Clarivate

MAY 31, 2023

A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. billion in 2022. of AbbVie’s $51.8 billion in revenue to a whopping 67.2%

Pharma 52

Pharma Biopharma Medicine Healthcare 52

Clarivate

MAY 8, 2024

According to BioWorld, M&A values in 2023 jumped 80% over 2022, and deal values reached BioWorld’s highest level ever recorded. Following high-dollar deals in 2022 for antibody drug conjugates (ADCs) in the oncology space with Mersana Therapeutics and Kelun-Biotech, Merck/MSD once again led biopartnering activity in 2023.

Pharma 59

Pharma Biopharma Prospecting Competition 59

Clarivate

JANUARY 23, 2024

R&D productivity fell in 2022, but late-phase cancellations are also trending down The rise and fall of R&D productivity across the global biopharmaceutical industry is a well-documented and much discussed topic, with industry commentators quantifying productivity in many ways (e.g.,

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. During 2019–21, when sales being close to predicted levels resulted in single-digit payback rates, the scheme was relatively popular with the pharma sector. billion ($4.1

Government 97

Government Pharma Sales Medicine 97

MedCity News

JUNE 16, 2023

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 108

Pharma Food and Drug Administration Recruitment Patients 108

European Pharmaceutical Review

JANUARY 16, 2023

According to 2022 data gathered by the World Health Organization (WHO), there are around 24 million schizophrenia patients. “Rykindo ® is our first new drug developed in-house and approved for marketing in the US,” declared Yang Rongbing, President of Luye Pharma Group. Promising schizophrenia drug faces tough competition.

Food and Drug Administration 122

Food and Drug Administration FDA Competition Pharma 122

Pharmaceutical Technology

MAY 11, 2023

The global pharma industry experienced a 9% drop in social media posts on internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for U.S. Of the 50 leading companies in the pharma industry, U.S. Buy the report here.

Media 52

Media Pharma Competition Marketing 52

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 109

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 109

PM360

JUNE 26, 2023

In its 2022 edition, the Access to Medicine Foundation report 2 analyzed the access strategy of 180 products across the top 20 pharmaceutical companies, of which 102 are on the WHO essential medicine list. Access to Medicine Index 2022”: link Firstly, entering new markets and increasing sales should boost revenue. References: 1.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

PharmaKinnex

AUGUST 23, 2022

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! August 23, 2022. The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. What are these new and existing pharma regulations, expectations, and challenges? dstansberry@costellocreativegroup.com.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. Are you intrigued to know what technologies will rule the pharma market and how they can benefit your business in 2023? from 2022 to 2030, the pharma industry will reach USD 9,241.34 billion during 2020-2024.

Pharma 52

Pharma Medicine Marketing Prospecting 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 91

Medicine Healthcare Healthcare Pharma 91

PharmExec

MARCH 10, 2024

Yet, pharma brands spent over $12.5 billion in 2022 to engage and influence with HCP-to-HCP activities. This paper explores how to filter and pinpoint critical data sets using browser-based technology to gain marketing insights from this data and measure competitiveness.¬

Competition 40

Competition Sales Marketing Pharma 40

PharmaKinnex

APRIL 18, 2022

Success Guidelines For Pharma Contract Inside Sales Forces April 18, 2022. The benefits of which provide pharma companies with flexibility and scalability. It cultivates healthy competition and allows each team member to motivate and empower each other. Inside Sales vs Outside Sales, What is the Difference?

Sales 52

Sales Pharma Physicians Electronics 52

Quantified

OCTOBER 31, 2022

Sales coaching has remained relatively the same for the past few decades, with promising technologies like AI still considered alternative to some pharma sales organizations. To put it bluntly, it’s harder than ever for reps to sell or for pharmas to remain profitable. What’s driving the need for a sales coaching revolution?

Sales 52

Sales Pharma Training Interpersonal Skills 52

Celeritas

NOVEMBER 7, 2022

The provision of a competitive advantage over other dairy suppliers also plays a major role in the considerations. The post The Value of Precision Livestock Farming (PLF) in 2022 appeared first on Celeritas | Digital Consulting. Effort Expectancy. This regards the perceived complexity involved in the operation of the system.

Networking 52

Networking Pharmaceutical products Management Transportation 52

European Pharmaceutical Review

NOVEMBER 16, 2023

With procurement practices across Europe having a strong price focus, over time, this could impact the “sustainability of biosimilars and decrease competition, as well as reducing supply reliability”, the report acknowledged. “As Act4Biosimilars is supported by its founding sponsor, Sandoz.

Marketing 110

Marketing Education Competition Consulting 110

Clarivate

OCTOBER 10, 2022

Clarivate oncology experts share key takeaways from the 2022 ESMO Congress and their expected impact on the drug treatment landscape and patients. Read on to for insights from our analysts on: Global highlights from ESMO 2022. Key ESMO 2022 highlights from Mainland China. Seven global highlights from ESMO 2022.

Marketing 52

Marketing Safety Patients Competition 52

PM360

JULY 26, 2023

Since passage of the Inflation Reduction Act (IRA) in August 2022, the focus of many industry analysts and pharmaceutical companies has been on two important first order concerns: identifying products to be negotiated by the Centers for Medicare & Medicaid Services (CMS) and assessing the direct impact on prices.

Manufacturing 98

Manufacturing Pharma Competition Distribution 98

pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Competition 80

Competition Pharma Sales Medicine 80

Pharmaceutical Technology

DECEMBER 15, 2022

On November 16, 2022, Medicines for Europe (MFE), the generics and biosimilars body, called for EU and national reforms to improve the security of medicine supplies, including tackling the impact of inflation on the security of essential medicine supplies with smart procurement guidelines for medicine.

Transportation 98

Transportation Medicine Manufacturing Pharma 98

pharmaphorum

SEPTEMBER 21, 2022

Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US. The US Court of Appeals for the Federal Circuit (CAFC) has denied the Swiss pharma group’s petition to rehear its decision on the validity of US Patent No. Gilenya made revenues of $2.8

Competition 52

Competition Pharma Sales Marketing 52

Pharmaceutical Technology

DECEMBER 20, 2022

trillion in Q2 2022 to $3.14 trillion in Q3, according to GlobalData’s Pharma Intelligence Center Companies Database. The growing competition from generic drugs presents challenges for the top 20 players placing pressure on drug prices. and 10%, respectively. GSK and Sanofi’s share prices dropped sharply by 46.4%

Biopharma 52

Biopharma Marketing Sales Competition 52

European Pharmaceutical Review

JUNE 8, 2023

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

Biopharma 98

Biopharma Government Training Education 98

Impetus Digital

MARCH 15, 2024

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying.

Recruitment 79

Recruitment Healthcare Provider Patients Healthcare 79

European Pharmaceutical Review

FEBRUARY 27, 2023

Due to more biopharmaceutics classification system (BCS) II and BCS IV molecules being evaluated in early development, a market report has signalled that the bioavailability enhancement market will grow at a steady rate between 2022 to 2035.

Marketing 98

Marketing Distribution Pharmaceutical Competition 98

pharmaphorum

JANUARY 9, 2023

Regulatory divergence became apparent in 2022 and could increase in 2023. For pharma, the impact in critical areas such as the performance of newly marketed innovation has already been documented. Pharma is on a journey in which the core consideration was once the prescriber, now patient needs are more commonly considered as central.

Medicine 86

Medicine Healthcare Healthcare Pharma 86

pharmaphorum

OCTOBER 18, 2022

The Swiss pharma group reported “significantly lower” sales of COVID-19-related products that offset growth in other products like Ocrevus (ocrelizumab) for multiple sclerosis, haemophilia therapy Hemlibra (emicizumab), Evrysdi (risdiplam) for spinal muscular atrophy and breast cancer drug Phesgo (pertuzumab/trastuzumab/hyaluronidase).

Sales 52

Sales Medicine Pharma Competition 52

European Pharmaceutical Review

JULY 18, 2022

The deal is expected to close by the end of 2022, subject to approval by the relevant competition authorities. We are committed to facilitating access to treatment for even more patients in need,” commented Gabriel Baertschi, CEO of Grünenthal.

Medicine 98

Medicine Physicians Competition Patients 98

World of DTC Marketing

JUNE 13, 2022

If pharma wants to retain people, they may have to develop a solution to lower healthcare insurance premiums. percent in 2022, even after taking cost-management initiatives into account, according to recent employer surveys. Right now, annual raises are being neutralized by increasing healthcare insurance premiums. percent and 5.2

Insurance 201

Insurance Healthcare Healthcare Consulting 201